Oxford Global, Radisson Blu, London
3rd and 4th November 2016
Oxford Global are proud to present the 5th Annual Cell Culture & Bioprocessing Congress, taking place on the 3-4 November 2016 at the Radisson Blu Portman Hotel in London.
This Congress is an executive platform for over 170 experts to network, exchange ideas, and discuss the latest innovations in the field. Delegates come from a variety of areas, including cell line development, cell line engineering, up and downstream operations, biotechnology, process development, biologics production and more.
Over 170 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
50 presentations, case studies and panel discussions focused on the key issues in cell line optimisation, process development and biological production
4 interactive streams:
- Cell Line Development: Stem Cells, Genome-Editing, CRISPR & NGS - Process Development - Cell Line Development: Mammalian & Bacterial Expression Systems - Biological Production
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.
This Congress is an executive platform for over 170 experts to network, exchange ideas, and discuss the latest innovations in the field. Delegates come from a variety of areas, including cell line development, cell line engineering, up and downstream operations, biotechnology, process development, biologics production and more.
On Day One, the conference will address stem cell development, gene-editing, cell genome NGS sequencing and CRISPR technology. Our expert speakers will discuss technologies for precise genome editing as well as the potential uses gene editing could have in future, how to ensure quality of raw materials in stem cell culture, and 3D cell culture technologies. Key issues to be covered in our Process Development stream include novel single use technologies, analytics development and the processing of Bispecific antibodies.
Day two of the event will see our leading industry and academic speakers present subjects such as the optimisation of cell lines, contamination issues in manufacture, efficient technology transfer, strategies in the use of Quality by Design, and the future of continuous processing. Other key topics that delegates will have the opportunity to hear about include first hand experiences from speakers of biosimilar cell line development, and innovation in the early development of bispecific antibodies. Our cell line development stream will have a focus on innovation in the use of both mammalian and bacterial expression systems.
|
|
|
Invited Speakers:
|
|
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. Our list of speakers includes: - Orit Aharonovitz, Head of Molecular & Cell Biology, Teva Pharmaceuticals - Arna Andrews, Director, Cell Line Development, CSL Limited - Martin Bertschinger, Senior Team Leader Cell Line and Early Process Development - Arnaud Brisson, Head of Upstream Process Development, Sanofi - Darya Burakov, Associate Director, Regeneron - Maire Caparon, Associate Research Fellow, Pfizer - Oliver Chao, Head of Emerging Biomedical Sciences, Sanofi - Rob de Jong, Assistant Director CMC Research & Protein Chemistry, Genmab
|
|